Study With Mosunetuzumab and Zanubrutinib in R/R Follicular Lymphoma Patients
Clinical trial NCT06492837 · RECRUITING
Trial details
- NCT number
- NCT06492837
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-23
- Primary completion
- 2028-09-15
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.